These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12239147)

  • 1. Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors.
    Kottaridis PD; Gale RE; Langabeer SE; Frew ME; Bowen DT; Linch DC
    Blood; 2002 Oct; 100(7):2393-8. PubMed ID: 12239147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse.
    Shih LY; Huang CF; Wu JH; Lin TL; Dunn P; Wang PN; Kuo MC; Lai CL; Hsu HC
    Blood; 2002 Oct; 100(7):2387-92. PubMed ID: 12239146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples.
    Cloos J; Goemans BF; Hess CJ; van Oostveen JW; Waisfisz Q; Corthals S; de Lange D; Boeckx N; Hählen K; Reinhardt D; Creutzig U; Schuurhuis GJ; Zwaan ChM; Kaspers GJ
    Leukemia; 2006 Jul; 20(7):1217-20. PubMed ID: 16642044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLT3-TKD mutation in childhood acute myeloid leukemia.
    Liang DC; Shih LY; Hung IJ; Yang CP; Chen SH; Jaing TH; Liu HC; Wang LY; Chang WH
    Leukemia; 2003 May; 17(5):883-6. PubMed ID: 12750701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
    Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC
    Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous patterns of FLT3 Asp(835) mutations in relapsed de novo acute myeloid leukemia: a comparative analysis of 120 paired diagnostic and relapse bone marrow samples.
    Shih LY; Huang CF; Wu JH; Wang PN; Lin TL; Dunn P; Chou MC; Kuo MC; Tang CC
    Clin Cancer Res; 2004 Feb; 10(4):1326-32. PubMed ID: 14977832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative, real-time polymerase chain reactions for FLT3 internal tandem duplications are highly sensitive and specific.
    Stirewalt DL; Willman CL; Radich JP
    Leuk Res; 2001 Dec; 25(12):1085-8. PubMed ID: 11684280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal residual disease based on patient specific Flt3-ITD and -ITT mutations in acute myeloid leukemia.
    Scholl S; Loncarevic IF; Krause C; Kunert C; Clement JH; Höffken K
    Leuk Res; 2005 Jul; 29(7):849-53. PubMed ID: 15921740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemia.
    Kottaridis PD; Gale RE; Linch DC
    Leuk Lymphoma; 2003 Jun; 44(6):905-13. PubMed ID: 12854887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia.
    Wakita S; Yamaguchi H; Omori I; Terada K; Ueda T; Manabe E; Kurosawa S; Iida S; Ibaraki T; Sato Y; Todoroki T; Hirakawa T; Ryotokuji T; Arai K; Kitano T; Mitamura Y; Kosaka F; Dan K; Inokuchi K
    Leukemia; 2013 Apr; 27(5):1044-52. PubMed ID: 23135354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor.
    Chillón MC; Fernández C; García-Sanz R; Balanzategui A; Ramos F; Fernández-Calvo J; González M; Miguel JF
    Hematol J; 2004; 5(3):239-46. PubMed ID: 15167911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLT3 mutations in myeloid sarcoma.
    Ansari-Lari MA; Yang CF; Tinawi-Aljundi R; Cooper L; Long P; Allan RH; Borowitz MJ; Berg KD; Murphy KM
    Br J Haematol; 2004 Sep; 126(6):785-91. PubMed ID: 15352981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myelogenous leukemia with internal tandem duplication of the Flt3 gene appearing or altering at the time of relapse: a report of two cases.
    Hovland R; Gjertsen BT; Bruserud O
    Leuk Lymphoma; 2002 Oct; 43(10):2027-9. PubMed ID: 12481903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of FLT3 ITD and D835 mutations in AML patients.
    Sheikhha MH; Awan A; Tobal K; Liu Yin JA
    Hematol J; 2003; 4(1):41-6. PubMed ID: 12692519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA.
    Jilani I; Estey E; Manshuri T; Caligiuri M; Keating M; Giles F; Thomas D; Kantarjian H; Albitar M
    Leukemia; 2003 Jan; 17(1):114-9. PubMed ID: 12529667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.
    Stirewalt DL; Kopecky KJ; Meshinchi S; Appelbaum FR; Slovak ML; Willman CL; Radich JP
    Blood; 2001 Jun; 97(11):3589-95. PubMed ID: 11369655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLT3 mutations in acute myeloid leukemia cell lines.
    Quentmeier H; Reinhardt J; Zaborski M; Drexler HG
    Leukemia; 2003 Jan; 17(1):120-4. PubMed ID: 12529668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor.
    Tse KF; Allebach J; Levis M; Smith BD; Bohmer FD; Small D
    Leukemia; 2002 Oct; 16(10):2027-36. PubMed ID: 12357354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.
    Callens C; Chevret S; Cayuela JM; Cassinat B; Raffoux E; de Botton S; Thomas X; Guerci A; Fegueux N; Pigneux A; Stoppa AM; Lamy T; Rigal-Huguet F; Vekhoff A; Meyer-Monard S; Ferrand A; Sanz M; Chomienne C; Fenaux P; Dombret H;
    Leukemia; 2005 Jul; 19(7):1153-60. PubMed ID: 15889156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia.
    Nazha A; Cortes J; Faderl S; Pierce S; Daver N; Kadia T; Borthakur G; Luthra R; Kantarjian H; Ravandi F
    Haematologica; 2012 Aug; 97(8):1242-5. PubMed ID: 22532519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.